Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2.2M | 223 | 98.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,940 | 11 | 0.7% |
| Unspecified | $13,180 | 13 | 0.6% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1.9M | 232 | $0 (2021) |
| Janssen Research & Development, LLC | $349,334 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $339,085 | 13 | Janssen Research & Development, LLC ($339,085) |
| 2021 | $2,100 | 5 | PFIZER INC. ($2,100) |
| 2020 | $522,352 | 59 | PFIZER INC. ($522,352) |
| 2019 | $449,207 | 60 | PFIZER INC. ($449,207) |
| 2018 | $458,153 | 55 | PFIZER INC. ($458,153) |
| 2017 | $467,533 | 55 | PFIZER INC. ($457,284) |
All Payment Transactions
247 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Research & Development, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $11,497.50 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Janssen Research & Development, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $8,395.00 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Janssen Research & Development, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $20,987.50 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Janssen Research & Development, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $10,402.50 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Janssen Research & Development, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $10,585.00 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Janssen Research & Development, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $16,607.50 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Janssen Research & Development, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $9,672.50 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Janssen Research & Development, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $7,847.50 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Janssen Research & Development, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $44,347.50 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Janssen Research & Development, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $9,490.00 | General |
| Category: Immunology | ||||||
| 08/19/2024 | Janssen Research & Development, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $96,360.00 | General |
| Category: Immunology | ||||||
| 06/10/2024 | Janssen Research & Development, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $20,075.00 | General |
| Category: Immunology | ||||||
| 05/03/2024 | Janssen Research & Development, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $72,817.50 | General |
| Category: Immunology | ||||||
| 09/13/2021 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: RITLECITINIB CLINICAL PUBLICATION PROGRAM | ||||||
| 09/10/2021 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: RITLECITINIB CLINICAL PUBLICATION PROGRAM | ||||||
| 09/07/2021 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: RITLECITINIB CLINICAL PUBLICATION PROGRAM | ||||||
| 08/18/2021 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: RITLECITINIB CLINICAL PUBLICATION PROGRAM | ||||||
| 06/02/2021 | PFIZER INC. | — | — | In-kind items and services | $780.00 | Research |
| Study: RITLECITINIB CLINICAL PUBLICATION PROGRAM | ||||||
| 12/27/2020 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $7,766.63 | General |
| 12/06/2020 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $10,608.08 | General |
| 11/29/2020 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $8,334.92 | General |
| 11/22/2020 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $10,418.65 | General |
| 11/15/2020 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $11,271.09 | General |
| 11/12/2020 | PFIZER INC. | — | — | In-kind items and services | $3,200.00 | Research |
| Study: RITLECITINIB CLINICAL PUBLICATION PROGRAM | ||||||
| 11/10/2020 | PFIZER INC. | — | — | In-kind items and services | $780.00 | Research |
| Study: RITLECITINIB CLINICAL PUBLICATION PROGRAM | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RITLECITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $10,840 | 10 |
| INFLAMIMMUNO CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,560 | 2 |
| JAK 3TEC CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $780.00 | 1 |
About Lori Ann Cox
Lori Ann Cox is a Rheumatology healthcare provider based in New Brunswick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437229143.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lori Ann Cox has received a total of $2.2M in payments from pharmaceutical and medical device companies, with $339,085 received in 2024. These payments were reported across 247 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($2.2M).
Practice Information
- Specialty Rheumatology
- Location New Brunswick, NJ
- Active Since 11/09/2006
- Last Updated 02/07/2008
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1437229143
Products in Payments
- TREMFYA (Drug) $339,085
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in New Brunswick
Victor Sloan
Rheumatology — Payments: $158,306
Dr. Naomi Schlesinger, Md, MD
Rheumatology — Payments: $62,444
Vivien Hsu, Md, MD
Rheumatology — Payments: $53,308
Leonard Sigal
Rheumatology — Payments: $12,528
Mahboob Rahman, Md, MD
Rheumatology — Payments: $960.40
Dr. Kyle Park, Md, MD
Rheumatology — Payments: $674.94